Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C-Reference-Cited by-同舟云学术

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

Published:2014-02-28 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hauser Goran¹²,Awad Tahany²,Thorlund Kristian³,Štimac Davor¹,Mabrouk Mahasen⁴,Gluud Christian²

Affiliation:

1. Clinical Hospital Centre Rijeka; Department of Gastroenterology; Kresimirova 42 Rijeka Croatia 51 000

2. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Department 7812, Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark

3. McMaster University; Department of Clinical Epidemiology and Biostatistics; Hamilton Ontario Canada

4. Faculty of Medicine, Cairo University; Endemic Medicine and Liver Department; Cairo Egypt

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005642.pub3/fullpdf

Reference125 articles.

1. Peginterferon alfa-2a plus ribavirin Is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection;Ascione;Gastroenterology,2010

2. Peginterferon alpha-2a plus ribavirin versus peginterferon alpha-2b plus ribavirin in naive patients with chronic hepatitis C virus infection: results of a prospective randomised trial. Abstracts of the 43rd Annual Meeting of the European Association for the Study of the Liver;Ascione;Hepatology,2008

3. Randomized, open label trial comparing efficacy and safety of pegylated interferon alfa 2A vs alfa 2B treatment of patients with chronic hepatitis C infected with non 2/3 genotypes-12 week virological response analysis;Berak;Hepatology,2005

4. Viral dynamics and pharmacokinetics of peginterferon alpha-2a and peginterferon alpha-2b in naive patients with chronic hepatitis C: a randomized, controlled study;Bruno;Antiviral Therapy,2004

5. Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C;Bruno;Antiviral Therapy,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Compliance and Efficacy of Pegylated Interferon α-2a and α-2b in Adults with Chronic Hepatitis C;Journal of Interferon & Cytokine Research;2019-04

2. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus;Revista do Instituto de Medicina Tropical de São Paulo;2017-11-06

3. Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2015-04-14

4. Aminoadamantanes versus other antiviral drugs for chronic hepatitis C;Cochrane Database of Systematic Reviews;2014-06-17

5. Aminoadamantanes for chronic hepatitis C;Cochrane Database of Systematic Reviews;2014-05-03